← Back to Patent Explorer
US4427670A Expired / Lapsed US ⏱️ 0.0 years remaining

Skin preparation

Assignee: Mitsubishi Chemical Corp
•
Filing: 1982-02-10
•
Granted: 1984-01-24
•
Expires: 2002-02-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Skin preparations containing a phosphatide, a topical corticosteroid, and butylhydroxyanisole and/or butylhydroxytoluene, which may be in the form of an aqueous or oily mixture, non-aqueous, water-soluble base or suspension base. These preparations can be applied to various skin diseases including eczema, lichen, ichthyosis and psoriasis, possess improved therapeutic activities and are stable for a prolonged period of time.

Inventors

  • 👤 Kunihiko Ofuchi
  • 👤 Koichiro Oda
  • 👤 Kenichiro Nakao

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 10:45
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/66; A61K31/683; A61K31/685; A61K47/00; A61K47/06; A61K47/08; A61K47/10; A61K47/24; A61K9/00; A61K9/0012; A61K9/0014; A61P; A61P17/00

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 62 words
A skin preparation containing at least one topical corticosteroid selected from the group consisting of diflucortolone valerate, diflucortolone pivalate, flucortin butyl, fluocortolone, clocortolone pivalate, halcinonide, amcinonide, diflorasone diacetate, desoxymethasone, difluprednate, desonide, budesonide, prednisone, paramethasone, fludroxycortide and flunisolide, and an effective amount of a phosphatide and at least one of butylhydroxyanisole and butylhydroxytoluene to impart stability to the preparation for a prolonged period.
Claim 2
Dependent Claim 62 words
A skin preparation containing at least one topical corticosteroid selected from the group consisting of diflucortolone valerate, diflucortolone pivalate, flucortin butyl, fluocortolone, clocortolone pivalate, halcinonide, amcinonide, diflorasone diacetate, desoxymethasone, difluprednate, desonide, budesonide, prednisone, paramethasone, fludroxycortide and flunisolide, and an effective amount of a phosphatide and at least one of butylhydroxyanisole and butylhydroxytoluene to impart stability to the preparation for a prolonged period.

References Cited (Backward Citations)

US4282216A Cited
US4333927A Cited
US4340594A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-01-23 1987-07-25 1988-01-24 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-01-23 1991-07-25 1992-01-24 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-01-23 1995-07-25 1996-01-24 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag